Ove Almkvist researcher
Almkvist, Ove, 1942-
Almkvist, Ove
Almkvist, Ove, 19..-
VIAF ID: 29518475 (Personal)
Permalink: http://viaf.org/viaf/29518475
Preferred Forms
-
- 100 1 _ ‡a Almkvist, Ove
- 100 1 _ ‡a Almkvist, Ove, ‡d 19..-
- 100 1 _ ‡a Almkvist, Ove, ‡d 1942-
- 100 0 _ ‡a Ove Almkvist ‡c researcher
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
Dual tracer tau PET imaging reveals different molecular targets for C-THK5351 and C-PBB3 in the Alzheimer brain | |
Early cognitive impairment in a subset of patients with presumed low-grade glioma. | |
Early diagnosis of Alzheimer dementia based on clinical and biological factors | |
The effect of memory on children's transitive inferences | |
Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease | |
Estimation of premorbid cognitive function based on word knowledge: the Swedish Lexical Decision Test | |
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease | |
Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup | |
A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation. | |
Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease. | |
Global dimensional complexity of multichannel EEG in mild Alzheimer's disease and age-matched cohorts. | |
Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation. | |
Health-adjusted neuropsychological test norms based on 463 older Swedish car drivers. | |
High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters | |
Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients. | |
Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm | |
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment | |
Impaired motor speed, visuospatial episodic memory and verbal fluency characterize cognition in long-term stroke survivors: the Tromsø Study. | |
Impairment of neocortical metabolism predicts progression in Alzheimer's disease. | |
The importance of impaired physical health and age in normal cognitive aging. | |
Including a subject-paced trial may make the PASAT more acceptable for MS patients. | |
Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon4. | |
Increased sensitivity in mapping task demand in visuospatial processing using reaction-time-dependent hemodynamic response predictors in rapid event-related fMRI. | |
Increasing CSF phospho-tau levels during cognitive decline and progression to dementia. | |
Insidious cognitive decline in CADASIL. | |
Investigating medical decision-making capacity in patients with cognitive impairment using a protocol based on linguistic features. | |
Is pyridine odor deficit related to progression of dementia in Alzheimer's disease? | |
Kognitionspsykologi : en introduktion. | |
Lexical and semantic ability in groups of children with cochlear implants, language impairment and autism spectrum disorder | |
Life situation, coping and quality of life in people with high and low risk of developing Alzheimer's disease. | |
Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease. | |
Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia. | |
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers. | |
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment | |
MRI in successful aging, a 5-year follow-up study from the eighth to ninth decade of life. | |
Neuropsychiatric function of housepainters with previous long-term heavy exposure to organic solvents | |
Neuropsychological dysfunction two years after subarachnoidal haemorrhage : relation to acute and long-term brain damage severity | |
Neuropsychological test norms controlled for physical health: does it matter? | |
Odor detectability in successfully aged elderly and young adults | |
Outcome measures in Alzheimer's disease: do they go far enough? | |
Patterns of functioning in older adults with mild cognitive impairment: a two-year study focusing on everyday technology use | |
Patterns of neuropsychological performance in Alzheimer's disease and vascular dementia. | |
PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease. | |
PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD. | |
Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease | |
Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's Disease. | |
Prevalence and correlates of successful aging in a population-based sample of older adults: the HUNT study. | |
A principal component model of medical health: implications for cognitive deficits and decline among adults in a population-based sample. | |
Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer's disease. | |
Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. | |
Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test. | |
Reading words with irregular decoding rules: a test of premorbid cognitive function? | |
Recognition memory for emotional faces in amnestic mild cognitive impairment: an event-related potential study. | |
Reduced neuronal efficacy in progressive mild cognitive impairment: a prospective fMRI study on visuospatial processing | |
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study. | |
Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjects. | |
Regional tau deposition measured by [(18)F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease | |
The Relationship Between Cognition and Daily Activities in Cases of Mild Alzheimer's Disease | |
Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients | |
Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study. | |
Selective impact of disease on short-term and long-term components of self-reported memory: a population-based HUNT study. | |
Self- and informant ratings of personality in mild cognitive impairment, reviewed. | |
The short human figure drawing scale for evaluation of suspect cognitive dysfunction in old age. | |
Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study | |
Skin vessel reactivity is impaired in Alzheimer's disease | |
Subjective working and declarative memory in dementia and normal aging | |
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months | |
Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device | |
Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers. | |
Tone duration discrimination in demented, memory-impaired, and healthy elderly. | |
Utökad diagnostik för åldersdementa med jämförande intellektuella test | |
Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. | |
Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment | |
White matter changes in familial Alzheimer's disease. | |
White-matter hyperintensity and neuropsychological functions in dementia and healthy aging | |
White matter lesions impair initiation of FAS flow. | |
Word fluency performance and strategies in children with cochlear implants: age-dependent effects? |